Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis

(Background) Lopinavir-ritonavir (LPV/RTV) is a human immunodeficiency virus (HIV) antiviral combination that has been considered for the treatment of COVID-19 disease. (Aim) This systematic review aimed to assess the efficacy and safety of LPV/RTV in COVID-19 patients in the published research. (Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhumaid, Saad, Al Mutair, Abbas, Al Alawi, Zainab, Alhmeed, Naif, Zaidi, Abdul Rehman Zia, Tobaiqy, Mansour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768433/
https://www.ncbi.nlm.nih.gov/pubmed/33260553
http://dx.doi.org/10.3390/tropicalmed5040180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768433/
https://www.ncbi.nlm.nih.gov/pubmed/33260553
http://dx.doi.org/10.3390/tropicalmed5040180

Ejemplares similares